Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 675

1.

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.

Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, Mintz ED, Widdowson MA.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S76-84. doi: 10.1086/605058.

2.

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.

Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S195-202. doi: 10.1086/605040.

3.

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.

Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.

J Infect Dis. 2005 Nov 15;192(10):1720-6. Epub 2005 Oct 14.

4.

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.

Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S16-27. doi: 10.1086/605026. Review.

5.

Cost-effectiveness and potential impact of rotavirus vaccination in the United States.

Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI.

Pediatrics. 2007 Apr;119(4):684-97.

PMID:
17403839
6.

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S133-45.

7.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

8.

Economic impact of a rotavirus vaccination program in Mexico.

Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y.

Rev Panam Salud Publica. 2009 Jun;25(6):481-90.

9.

Cost-effectiveness of childhood rotavirus vaccination in Taiwan.

Wu CL, Yang YC, Huang LM, Chen KT.

Vaccine. 2009 Mar 4;27(10):1492-9. doi: 10.1016/j.vaccine.2009.01.023. Epub 2009 Jan 30.

PMID:
19186200
10.

Cost and cost-effectiveness of childhood vaccination against rotavirus in France.

Melliez H, Levybruhl D, Boelle PY, Dervaux B, Baron S, Yazdanpanah Y.

Vaccine. 2008 Jan 30;26(5):706-15. doi: 10.1016/j.vaccine.2007.11.064. Epub 2007 Dec 17.

PMID:
18166250
11.

Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.

Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2010 Jan;41(1):114-25.

PMID:
20578490
12.

Economic evaluation of a routine rotavirus vaccination programme in Indonesia.

Wilopo SA, Kilgore P, Kosen S, Soenarto Y, Aminah S, Cahyono A, Ulfa M, Tholib A.

Vaccine. 2009 Nov 20;27 Suppl 5:F67-74. doi: 10.1016/j.vaccine.2009.09.040.

PMID:
19931723
13.

Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.

Ortega O, El-Sayed N, Sanders JW, Abd-Rabou Z, Antil L, Bresee J, Mansour A, Adib I, Nahkla I, Riddle MS.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S92-8. doi: 10.1086/605057.

14.

[Potential cost effectiveness of a rotavirus vaccine in Chile].

Constenla D, O'Ryan M, Navarrete MS, Antil L, Rheingans RD.

Rev Med Chil. 2006 Jun;134(6):679-88. Epub 2006 Aug 14. Spanish.

15.

Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.

Chodick G, Waisbourd-Zinman O, Shalev V, Kokia E, Rabinovich M, Ashkenazi S.

Eur J Public Health. 2009 Jun;19(3):254-9. doi: 10.1093/eurpub/ckp005. Epub 2009 Feb 12.

16.

Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China.

Liu N, Yen C, Fang ZY, Tate JE, Jiang B, Parashar UD, Zeng G, Duan ZJ.

Vaccine. 2012 Nov 6;30(48):6940-5. doi: 10.1016/j.vaccine.2012.05.084. Epub 2012 Jun 15.

PMID:
22705174
17.

Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine.

Isakbaeva ET, Musabaev E, Antil L, Rheingans R, Juraev R, Glass RI, Bresee JS.

Vaccine. 2007 Jan 4;25(2):373-80. Epub 2006 Aug 2.

PMID:
16930784
18.

Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.

Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S28-38. doi: 10.1086/605033.

19.

Disease and economic burden of rotavirus diarrhoea in India.

Tate JE, Chitambar S, Esposito DH, Sarkar R, Gladstone B, Ramani S, Raghava MV, Sowmyanarayanan TV, Gandhe S, Arora R, Parashar UD, Kang G.

Vaccine. 2009 Nov 20;27 Suppl 5:F18-24. doi: 10.1016/j.vaccine.2009.08.098.

PMID:
19931713
20.

Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.

Bilcke J, Van Damme P, Beutels P.

Med Decis Making. 2009 Jan-Feb;29(1):33-50. doi: 10.1177/0272989X08324955. Epub 2008 Oct 23.

PMID:
18948433
Items per page

Supplemental Content

Write to the Help Desk